Imidazo[4,5-d][1,3]diazepin-8-ol,3,4,7,8-tetrahydro-3-b-D-ribofuranosyl-, (8R)-
Names
[ CAS No. ]:
11033-22-0
[ Name ]:
Imidazo[4,5-d][1,3]diazepin-8-ol,3,4,7,8-tetrahydro-3-b-D-ribofuranosyl-, (8R)-
[Synonym ]:
Coformycin
Biological Activity
[Description]:
Coformycin, a nucleoside antibiotic, is a potent inhibitor of adenosine deaminase (ADA) from Streptomyces species. Coformycin possesses anti-tumor and anti-bacterial activity[1][2].
[Related Catalog]:
[In Vivo]
Coformycin (0.2 mg/kg, ip daily) inhibits adenosine deaminase activity for various tissues, including brain, heart, kidney, liver, etc[2]. Animal Model: Swiss-Webster mice[2]. Dosage: 0.2 mg/kg. Administration: IP daily. Result: Inhibited adenosine deaminase activity for various tissues.
[References]
Chemical & Physical Properties
[ Density]:
1.96g/cm3
[ Boiling Point ]:
692.7ºC at 760mmHg
[ Molecular Formula ]:
C11H16N4O5
[ Molecular Weight ]:
284.26900
[ Flash Point ]:
372.7ºC
[ Exact Mass ]:
284.11200
[ PSA ]:
132.36000
[ Vapour Pressure ]:
3.84E-20mmHg at 25°C
[ Index of Refraction ]:
1.828
Toxicological Information
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- NI2931500
- CHEMICAL NAME :
- Imidazo(4,5-d)(1,3)diazepin-8-ol, 3,4,7,8-tetrahydro-3-beta-D-ribofuranosyl-, (R)-
- CAS REGISTRY NUMBER :
- 11033-22-0
- LAST UPDATED :
- 198311
- DATA ITEMS CITED :
- 1
- MOLECULAR FORMULA :
- C11-H16-N4-O5
- MOLECULAR WEIGHT :
- 284.31
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 35 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- 85GDA2 "CRC Handbook of Antibiotic Compounds," Vols.1- , Berdy, J., Boca Raton, FL, CRC Press, 1980- Volume(issue)/page/year: 5,330,1981
Related Compounds
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.